ChemicalBook >> CAS DataBase List >>Necitumumab

Necitumumab

CAS No.
906805-06-9
Chemical Name:
Necitumumab
Synonyms
Necitumumab;IMC-11F8/LY301221;Necitumumab (anti-EGFR);Research Grade Necitumumab;Research Grade Necitumumab(DHB86901)
CBNumber:
CB33044071
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-04-24 14:58:30

Necitumumab Properties

form Liquid
color Colorless to light yellow
FDA UNII 2BT4C47RUI
NCI Dictionary of Cancer Terms necitumumab
NCI Drug Dictionary necitumumab
ATC code L01XC22

Pharmacokinetic data

Volume of distribution 6.97 Litres
Biological half-life 14 days / Unchanged

Necitumumab price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0031032 Necitumumab 99.81% 906805-06-9 1mg $238 2026-06-04 Buy
ChemScene CS-0031032 Necitumumab 99.81% 906805-06-9 5mg $715 2026-06-04 Buy
ChemScene CS-0031032 Necitumumab 99.81% 906805-06-9 10mg $1137 2026-06-04 Buy
Arctom HY-P9964 Necitumumab 99.81% 906805-06-9 1mg $168 2026-05-26 Buy
Arctom HY-P9964 Necitumumab 99.81% 906805-06-9 5mg $490 2026-05-26 Buy
Product number Packaging Price Buy
CS-0031032 1mg $238 Buy
CS-0031032 5mg $715 Buy
CS-0031032 10mg $1137 Buy
HY-P9964 1mg $168 Buy
HY-P9964 5mg $490 Buy

Necitumumab Chemical Properties, Uses, Production

Uses

Necitumumab is a human IgG monoclonal antibody directed against EGFR. Necitumumab can be used for research of NSCLC, colorectal cancer, etc[1].

Clinical Use

IgG1 monoclonal antibody:
Treatment of locally advanced or metastatic epidermal growth factor receptor (EGFR) expressing squamous non-small cell lung cancer

Drug interactions

Potentially hazardous interactions with other drugs
Live vaccines: avoid concomitant use.

Metabolism

The elimination routes of necitumumab are only partially documented, and involve degradation to peptides after being internalised into its target cells, proteolysis within the liver or the reticuloendothelial system, as well as nonspecific endocytosis.

References

[1] Garnock-Jones KP. Necitumumab: First Global Approval. Drugs. 2016 Feb;76(2):283-9. DOI:10.1007/s40265-015-0537-0

Necitumumab Preparation Products And Raw materials

Raw materials

Preparation Products

Necitumumab Suppliers

Global Suppliers ( 29)
Supplier Tel Email Country ProdList Advantage
Shanghai Synchem Pharma Co., ltd 21-619849051-1 18521059765 synchempharma@aliyun.com China 4988 55
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9799 58
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
ShangHai Biochempartner Co.,Ltd 177-54423994 17754423994 2853530910@QQ.com China 8000 62
BOC Sciences +1-631-485-4226 inquiry@bocsci.com United States 19935 58
Guangzhou Hongyuan Chemical Co.,Ltd 15817493340 981810490@qq.com China 1577 58
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 422450190@qq.com China 10305 58
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840 psaitong@jm-bio.com China 27626 58
Hubei Kele Fine Chemical Co., Ltd 027-59101668 19945030958 2223443625@qq.com China 7998 58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd. +86-027-59232304 15387063101 1276242629@qq.com China 9977 58
IMC-11F8/LY301221 Necitumumab Research Grade Necitumumab(DHB86901) Necitumumab (anti-EGFR) Research Grade Necitumumab 906805-06-9